Báo cáo hóa học: "Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-a 2b treatment"

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-a 2b treatment | Ascierto et al. Journal of Translational Medicine 2010 8 76 http content 8 1 76 RESEARCH JOURNAL OF TRANSLATIONAL MEDICINE Open Access Regulatory T cell frequency in patients with melanoma with different disease stage and course and modulating effects of high-dose interferon-a 2b treatment 1 1 1 1 1 1 Paolo A Ascierto Maria Napolitano Egidio Celentano Ester Simeone Giusy Gentilcore Antonio Daponte 1 r- I z- 1 1 1 1 Mariaelena Capone Corrado Caracò Rosa Calemma Gerardo Beneduce Margherita Cerrone inr Qn7 i rio Dr icsC fCii iconno Dtỉ Imiori2 ii TỉctollrC M ICirlztA r ir iH2 K l K r i n t I 4 Vincenzo De Rosa Giuseppe Palmieri Giuseppe Castello John M Kirkwood Francesco M Marincola Nicola Mozzillo 1 Abstract Background High-dose interferon-alpha 2b IFN-a 2b is the only approved systemic therapy in the United States for the adjuvant treatment of melanoma. The study objective was to explore the immunomodulatory mechanism of action for IFN-a 2b by measuring serum regulatory T cell Treg serum transforming growth factor-p TGF-P interleukin IL -10 and autoantibody levels in patients with melanoma treated with the induction phase of the high-dose IFN-a 2b regimen. Methods Patients with melanoma received IFN-a 2b administered intravenously 20 MU m2 each day from day 1 to day 5 for 4 consecutive weeks . Serum Treg levels were measured as whole lymphocytes in CD4 cells using flow cytometry while TGF-p IL-10 and autoantibody levels were measured using enzyme-linked immunosorbent assays. Results Twenty-two patients with melanoma received IFN-a 2b treatment and were evaluated for Treg levels. Before treatment Treg levels were significantly higher in patients with melanoma when compared with data from 20 healthy subjects P Mann-Whitney test . Although a trend for reduction of Treg levels following IFN-a 2b treatment was observed average decrease per week statistical significance was not achieved. Subgroup analyses indicated higher baseline

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.